Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
Published Online: 2022-08-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Aileen Cohen•Alessandra Tedeschi•Anders Österborg•Brad S Kahl•Carol Marimpietri•Constantine S Tam•Danielle M Brander•Emma Verner•Hanna Ciepluch•Henry Chan•Ian W Flinn•Jane Huang•Jason C Paik•Jennifer R Brown•Jianyong Li•Krzysztof Giannopoulos•Lei Zhou•Luca Laurenti•Marek Trněný•Martin Šimkovič•Mazyar Shadman•Monica Tani•Paolo Ghia•Patricia Walker•Peter Hillmen•Richard Greil•Sebastian Grosicki•Stephen Opat•Tadeusz Robak•Tian Tian•Wojciech Jurczak
